title: How to treat recurrences after Avastin treatment for neovascular AMD: stick to Avastin or switch to Lucentis?
authors: A
authors: A
authors: Wolf
authors: D
authors: D
authors: Kook
authors: R
authors: R
authors: Strauss
authors: A
authors: A
authors: Kampik
authors: C
authors: C
authors: Haritoglou
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy*; D008297:Male; D000069579:Ranibizumab; D012189:Retrospective Studies; D055502:Secondary Prevention; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D000069579:Ranibizumab